Postoperative Changes in Skeletal Muscle Mass Predict Survival of Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy

Postoperative changes in the SMI after CN predict OS for patients with mRCC. SMI kinetics is a novel biomarker that can serve as a useful surrogate for the prognosis of patients with mRCC undergoing CN.